Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)7,981Market Cap (Aug-2026)1.328 Billion USDWorld Rank (Jan-05-2024)17,815Market Cap (Jan-05-2024)0.202 Billion USDWorld Rank (Jul-30-2023)16,551Market Cap (Jul-30-2023)0.265 Billion USDWorld Rank (Dec-25-2022)17,769Market Cap (Dec-25-2022)0.210 Billion USDCompany Website
-
Monte Rosa Therapeutics Inc.
World Rank (Aug-2026)8,001Market Cap (Aug-2026)1.322 Billion USDWorld Rank (Jan-05-2024)15,682Market Cap (Jan-05-2024)0.304 Billion USDWorld Rank (Jul-30-2023)14,960Market Cap (Jul-30-2023)0.350 Billion USDWorld Rank (Dec-25-2022)14,146Market Cap (Dec-25-2022)0.384 Billion USDWorld Rank (Jan-07-2022)10,718Market Cap (Jan-07-2022)0.79 Billion USDAnnual Revenue in USD124 Million USDAnnual Net Income in USD-39 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Schrodinger Inc.
World Rank (Aug-2026)8,016Market Cap (Aug-2026)1.316 Billion USDWorld Rank (Jan-05-2024)5,184Market Cap (Jan-05-2024)2.332 Billion USDWorld Rank (Jul-30-2023)3,873Market Cap (Jul-30-2023)3.545 Billion USDWorld Rank (Dec-25-2022)7,039Market Cap (Dec-25-2022)1.344 Billion USDWorld Rank (Jan-07-2022)5,797Market Cap (Jan-07-2022)2.26 Billion USDAnnual Revenue in USD256 Million USDAnnual Net Income in USD-103 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileSchrodinger is the scientific leader in developing state of the art chemical simulation software for use in pharmaceutical, Biotechnology and Materials Research company. The headquarters is in USA.
Facts About CompanySchrodinger Annual Total Revenue for year ending Dec-2022 was 180 million USD and and Net loss for year ending Dec-2022 was -149 million USD.
Schrodinger Annual Total Revenue for year ending Dec-2021 was 137 million USD and and Net loss for year ending Dec-2021 was -100 million USD.
As on 2022, Schrodinger has 787 employees.
Company Website -
Staar Surgical Company
World Rank (Aug-2026)8,023Market Cap (Aug-2026)1.313 Billion USDWorld Rank (Jan-05-2024)6,979Market Cap (Jan-05-2024)1.426 Billion USDWorld Rank (Jul-30-2023)4,712Market Cap (Jul-30-2023)2.672 Billion USDWorld Rank (Dec-25-2022)4,905Market Cap (Dec-25-2022)2.333 Billion USDWorld Rank (Jan-07-2022)3,944Market Cap (Jan-07-2022)3.94 Billion USDAnnual Revenue in USD239 Million USDAnnual Net Income in USD-80 Million USDAnnual Results for Period EndingFor year ending January-2026Company ProfileSTAAR Surgical Company Designs, Develops, Manufactures and Markets Implantable Lenses for the Eye with companion delivery systems company. It provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The headquarters is in USA.
Company Website -
Cullinan Oncology Inc.
World Rank (Aug-2026)8,035Market Cap (Aug-2026)1.309 Billion USDWorld Rank (Jan-05-2024)13,291Market Cap (Jan-05-2024)0.447 Billion USDWorld Rank (Jul-30-2023)14,109Market Cap (Jul-30-2023)0.401 Billion USDWorld Rank (Dec-25-2022)12,838Market Cap (Dec-25-2022)0.469 Billion USDWorld Rank (Jan-07-2022)11,894Market Cap (Jan-07-2022)0.64 Billion USDAnnual Net Income in USD-220 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Inhibrx Inc.
World Rank (Aug-2026)8,088Market Cap (Aug-2026)1.296 Billion USDWorld Rank (Jan-05-2024)6,046Market Cap (Jan-05-2024)1.809 Billion USDWorld Rank (Jul-30-2023)7,998World Rank (Dec-25-2022)7,998Market Cap (Dec-25-2022)1.081 Billion USDWorld Rank (Jan-07-2022)8,138Market Cap (Jan-07-2022)1.29 Billion USDAnnual Revenue in USD1 Million USDAnnual Net Income in USD-140 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileInhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.Company Website -
Herbalife Nutrition
World Rank (Aug-2026)8,097Market Cap (Aug-2026)1.292 Billion USDWorld Rank (Jan-05-2024)6,985Market Cap (Jan-05-2024)1.425 Billion USDWorld Rank (Jul-30-2023)6,451Market Cap (Jul-30-2023)1.658 Billion USDWorld Rank (Dec-25-2022)6,794Market Cap (Dec-25-2022)1.414 Billion USDWorld Rank (Jan-07-2022)3,361Market Cap (Jan-07-2022)4.85 Billion USDAnnual Revenue in USD5,038 Million USDAnnual Net Income in USD228 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileHerbalife Nutrition is a Multi level marketing and Healthcare company. The company products are personalized protein powder, cell u loss advanced, cell activator tablets, multivitamin mineral and herbal tablets, herbal control, shakemate and formula 1 nutritional shake mix. Its nutrition, weight-management products are available exclusively through its more than 2.3 million independent Associates in more than 90 countries. The headquarters is in USA.
Company Website -
Alvotech
World Rank (Aug-2026)8,192Market Cap (Aug-2026)1.266 Billion USDWorld Rank (Jan-05-2024)4,162Market Cap (Jan-05-2024)3.219 Billion USDWorld Rank (Jul-30-2023)4,793Market Cap (Jul-30-2023)2.602 Billion USDWorld Rank (Dec-25-2022)4,680Market Cap (Dec-25-2022)2.487 Billion USDCompany ProfileThe company is a biotechnology company that manufactures biologic medicines like insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines. Headquarters is in Iceland.
Company Website -
Immatics N.V.
World Rank (Aug-2026)8,198Market Cap (Aug-2026)1.266 Billion USDWorld Rank (Jan-05-2024)9,099Market Cap (Jan-05-2024)0.908 Billion USDWorld Rank (Jul-30-2023)8,838Market Cap (Jul-30-2023)0.980 Billion USDWorld Rank (Dec-25-2022)10,806Market Cap (Dec-25-2022)0.649 Billion USDWorld Rank (Jan-07-2022)11,036Market Cap (Jan-07-2022)0.75 Billion USDCompany Website -
Corvus Pharmaceuticals
World Rank (Aug-2026)8,245Market Cap (Aug-2026)1.253 Billion USDWorld Rank (Jan-05-2024)21,283Market Cap (Jan-05-2024)0.103 Billion USDWorld Rank (Jul-30-2023)21,344Market Cap (Jul-30-2023)0.107 Billion USDWorld Rank (Dec-25-2022)26,383Market Cap (Dec-25-2022)0.039 Billion USDWorld Rank (Jan-07-2022)23,020Market Cap (Jan-07-2022)0.10 Billion USDAnnual Net Income in USD-15 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website